Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides

Published:1998 Issue:10 Volume:20 Page:825
ISSN:0379-0355
Container-title:Methods and Findings in Experimental and Clinical Pharmacology
language:en
Short-container-title:Methods Find Exp Clin Pharmacol

Author:

Rubenstein M.,Mirochnik Y.,Chou P.,Guinan P.

Publisher

Clarivate Analytics (US)

Subject

Pharmacology (medical),Pharmacology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics;Molecular Therapy - Nucleic Acids;2019-03

2. Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2;Medical Oncology;2009-06-16

3. Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2;Medical Oncology;2007-10-30

4. Bispecific antisense oligonucleotides with multiple binding sites for the treatment of prostate tumors and their applicability to combination therapy;Methods and Findings in Experimental and Clinical Pharmacology;2006

5. Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors;Medical Hypotheses;2005-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP